Latest News about FDA
Recent news which mentions FDA
Legal Psychedelics: Which Compounds Will Be Approved Next? MDMA, LSD Or Something Else?
August 20, 2023
Tickers
MDMA
From Benzinga
FDA Chooses Portable Cannabis Analyzer That Enables Non-Technical Operators To Instantly Test Marijuana Plants & Products
August 18, 2023
From Benzinga
U.S. Hemp Roundtable Members Respond To Congress On CBD Regulations, Here's What They Said
August 16, 2023
From Benzinga
Delcath Systems Stock Soars 90% In One Session - Here's Why
August 15, 2023
Tickers
DCTH
From Benzinga
FDA Gives Green Signal To Arcellx's Stopped Blood Cancer Study
August 15, 2023
Tickers
ACLX
From Benzinga
Logan Paul Challenges Schumer's Scrutiny Of PRIME's Caffeine Content: 'Why Aren't We Controlling This At The Point Of Purchase?'
August 10, 2023
From Benzinga
Lack Of Oversight Continues To Hurt Hemp Industry, What To Expect From 2023 Farm Bill
August 09, 2023
Tickers
HEMP
From Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
August 07, 2023
From Benzinga
Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial
August 04, 2023
Tickers
MESO
From Benzinga
Another Spending Bill Makes Its Way Through Senate, Could Amplify Marijuana & Psychedelics Research
August 03, 2023
From Benzinga
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.